<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drug\PMC7102582\results\search\disease\results.xml">
  <result pre=": bold;} span.year {font-family : courier ; font-style : italic;}" exact="Diabetes" post="Metab SyndrDiabetes Metab SyndrDiabetes &amp;amp; Metabolic Syndrome1871-40211878-0334Diabetes India. Published"/>
  <result pre="S1871-4021(20)30042-4 doi: 10.1016/j.dsx.2020.03.002 : Article Clinical considerations for patients with" exact="diabetes" post="in times of COVID-19 epidemic GuptaRiteshaGhoshAmertaaSinghAwadhesh KumarbMisraAnoopanoopmisra@gmail.comacdâˆ—[a], [b], [c],"/>
  <result pre="Chirag Enclave, New Delhi, India. anoopmisra@gmail.com pmc-release: 2020-3-3ppub: 2020epub: 2020-3-3143211212(C)" exact="Diabetes" post="India, 2020Since January 2020 Elsevier has created a COVID-19"/>
  <result pre="- including this research content - immediately available in PubMed" exact="Central" post="and other publicly funded repositories, such as the WHO"/>
  <result pre="remains active. 1 Background and epidemiology COVID-19 (Coronavirus Disease-2019), a" exact="disease" post="caused by the coronavirus SARS-CoV-2 (Severe Acute Respiratory Syndrome-Coronavirus-2),"/>
  <result pre="(Coronavirus Disease-2019), a disease caused by the coronavirus SARS-CoV-2 (Severe" exact="Acute" post="Respiratory Syndrome-Coronavirus-2), has emerged as a rapidly spreading communicable"/>
  <result pre="Disease-2019), a disease caused by the coronavirus SARS-CoV-2 (Severe Acute" exact="Respiratory" post="Syndrome-Coronavirus-2), has emerged as a rapidly spreading communicable disease"/>
  <result pre="(Severe Acute Respiratory Syndrome-Coronavirus-2), has emerged as a rapidly spreading" exact="communicable disease" post="affecting more than 100 countries across the globe at"/>
  <result pre="Acute Respiratory Syndrome-Coronavirus-2), has emerged as a rapidly spreading communicable" exact="disease" post="affecting more than 100 countries across the globe at"/>
  <result pre="more than 100 countries across the globe at present. The" exact="disease" post="is primarily spread through large respiratory droplets, though the"/>
  <result pre="globe at present. The disease is primarily spread through large" exact="respiratory" post="droplets, though the possibility of other routes of transmission"/>
  <result pre="found in stool and urine of affected individuals [1]. The" exact="disease" post="severity has varied from mild self-limiting flu-like illness to"/>
  <result pre="has varied from mild self-limiting flu-like illness to fulminant pneumonia," exact="respiratory" post="failure and death. There are regional variations in the"/>
  <result pre="Health Organisation on March 5, 2020 [2]. However, a much" exact="lower" post="mortality of 1.4% has been reported in analysis of"/>
  <result pre="is going on. The understanding of epidemiological characteristics of this" exact="infection" post="is evolving on a daily basis as the disease"/>
  <result pre="this infection is evolving on a daily basis as the" exact="disease" post="is spreading to different parts of the globe. 2"/>
  <result pre="is spreading to different parts of the globe. 2 Diabetes," exact="respiratory" post="infections and COVID19 Individuals with diabetes are at risk"/>
  <result pre="spreading to different parts of the globe. 2 Diabetes, respiratory" exact="infections" post="and COVID19 Individuals with diabetes are at risk of"/>
  <result pre="the globe. 2 Diabetes, respiratory infections and COVID19 Individuals with" exact="diabetes" post="are at risk of infections, especially influenza and pneumonia."/>
  <result pre="not completely eliminated, by good glycaemic control. All people with" exact="diabetes" post="(above 2 years of age) are recommended pneumococcal and"/>
  <result pre="pneumococcal and annual influenza vaccinations. Not only this, patients with" exact="diabetes" post="have a severe disease when infected with respiratory viruses."/>
  <result pre="vaccinations. Not only this, patients with diabetes have a severe" exact="disease" post="when infected with respiratory viruses. Indeed, diabetes was seen"/>
  <result pre="patients with diabetes have a severe disease when infected with" exact="respiratory" post="viruses. Indeed, diabetes was seen as an important risk"/>
  <result pre="have a severe disease when infected with respiratory viruses. Indeed," exact="diabetes" post="was seen as an important risk factor for mortality"/>
  <result pre="mortality in patients infected with Pandemic Influenza A 2009 (H1N1)," exact="Severe" post="Acute Respiratory Syndrome (SARS) coronavirus and Middle East Respiratory"/>
  <result pre="in patients infected with Pandemic Influenza A 2009 (H1N1), Severe" exact="Acute" post="Respiratory Syndrome (SARS) coronavirus and Middle East Respiratory Syndrome-related"/>
  <result pre="patients infected with Pandemic Influenza A 2009 (H1N1), Severe Acute" exact="Respiratory" post="Syndrome (SARS) coronavirus and Middle East Respiratory Syndrome-related coronavirus"/>
  <result pre="infected with Pandemic Influenza A 2009 (H1N1), Severe Acute Respiratory" exact="Syndrome" post="(SARS) coronavirus and Middle East Respiratory Syndrome-related coronavirus (MERSCoV)"/>
  <result pre="(H1N1), Severe Acute Respiratory Syndrome (SARS) coronavirus and Middle East" exact="Respiratory" post="Syndrome-related coronavirus (MERSCoV) [[5], [6], [7]]. Data about COVID-19"/>
  <result pre="(MERSCoV) [[5], [6], [7]]. Data about COVID-19 in patients with" exact="diabetes" post="is limited at present. Diabetes was present in 42.3%"/>
  <result pre="[6], [7]]. Data about COVID-19 in patients with diabetes is" exact="limited" post="at present. Diabetes was present in 42.3% of 26"/>
  <result pre="about COVID-19 in patients with diabetes is limited at present." exact="Diabetes" post="was present in 42.3% of 26 fatalities due to"/>
  <result pre="a study in 140 patients with COVID-19 in Wuhan, China," exact="diabetes" post="was not a risk factor for severe disease course"/>
  <result pre="Wuhan, China, diabetes was not a risk factor for severe" exact="disease" post="course [9]. However, another study in 150 patients (68"/>
  <result pre="patients with COVID-19 did not mention raised blood glucose or" exact="diabetes" post="as predictor of severe disease [11]. Notwithstanding these small"/>
  <result pre="mention raised blood glucose or diabetes as predictor of severe" exact="disease" post="[11]. Notwithstanding these small series, a report of 72,314"/>
  <result pre="of 72,314 cases of COVID-19 published by Chinese Centre for" exact="Disease" post="Control and Prevention showed increased mortality in people with"/>
  <result pre="Disease Control and Prevention showed increased mortality in people with" exact="diabetes" post="(2.3%, overall and 7.3%, patients with diabetes) [12]. 3"/>
  <result pre="prevent COVID-19 Our knowledge about the prevalence of COVID-19 and" exact="disease" post="course in people with diabetes will evolve as more"/>
  <result pre="the prevalence of COVID-19 and disease course in people with" exact="diabetes" post="will evolve as more detailed analyses are carried out."/>
  <result pre="For now, it is reasonable to assume that people with" exact="diabetes" post="are at increased risk of developing infection with SARS-CoV-2."/>
  <result pre="that people with diabetes are at increased risk of developing" exact="infection" post="with SARS-CoV-2. Coexisting heart disease, kidney disease, advanced age"/>
  <result pre="are at increased risk of developing infection with SARS-CoV-2. Coexisting" exact="heart" post="disease, kidney disease, advanced age and frailty are likely"/>
  <result pre="increased risk of developing infection with SARS-CoV-2. Coexisting heart disease," exact="kidney disease," post="advanced age and frailty are likely to have further"/>
  <result pre="of disease. Following measures are suggested for prevention of this" exact="disease" post="in patients with diabetes: A.Specific Measures in Patients with"/>
  <result pre="in Patients with Diabetes: a.It is important that people with" exact="diabetes" post="maintain a good glycaemic control, as it might help"/>
  <result pre="control, as it might help in reducing the risk of" exact="infection" post="and also the severity. More frequent monitoring of blood"/>
  <result pre="is required. Good glycemic control may lessen chances of superadded" exact="bacterial pneumonia" post="as well. b.Patients with diabetes and co-existing heart disease"/>
  <result pre="required. Good glycemic control may lessen chances of superadded bacterial" exact="pneumonia" post="as well. b.Patients with diabetes and co-existing heart disease"/>
  <result pre="lessen chances of superadded bacterial pneumonia as well. b.Patients with" exact="diabetes" post="and co-existing heart disease or kidney disease need special"/>
  <result pre="superadded bacterial pneumonia as well. b.Patients with diabetes and co-existing" exact="heart" post="disease or kidney disease need special care and attempts"/>
  <result pre="bacterial pneumonia as well. b.Patients with diabetes and co-existing heart" exact="disease" post="or kidney disease need special care and attempts should"/>
  <result pre="as well. b.Patients with diabetes and co-existing heart disease or" exact="kidney disease" post="need special care and attempts should be made to"/>
  <result pre="well. b.Patients with diabetes and co-existing heart disease or kidney" exact="disease" post="need special care and attempts should be made to"/>
  <result pre="or swimming pools. e.It is important to take influenza and" exact="pneumonia" post="vaccinations. The latter may decrease chances of secondary bacterial"/>
  <result pre="influenza and pneumonia vaccinations. The latter may decrease chances of" exact="secondary" post="bacterial pneumonia after respiratory viral infection, however, data in"/>
  <result pre="and pneumonia vaccinations. The latter may decrease chances of secondary" exact="bacterial pneumonia" post="after respiratory viral infection, however, data in present viral"/>
  <result pre="pneumonia vaccinations. The latter may decrease chances of secondary bacterial" exact="pneumonia" post="after respiratory viral infection, however, data in present viral"/>
  <result pre="The latter may decrease chances of secondary bacterial pneumonia after" exact="respiratory" post="viral infection, however, data in present viral epidemic is"/>
  <result pre="latter may decrease chances of secondary bacterial pneumonia after respiratory" exact="viral infection," post="however, data in present viral epidemic is not available."/>
  <result pre="bacterial pneumonia after respiratory viral infection, however, data in present" exact="viral" post="epidemic is not available. B.General Preventive Measures a.Thorough handwashing"/>
  <result pre="is also useful. b.There is a need to practise proper" exact="respiratory" post="hygiene with covering of mouth and nose with bent"/>
  <result pre="respiratory hygiene with covering of mouth and nose with bent" exact="elbow" post="or tissue when coughing or sneezing. Touching of mouth,"/>
  <result pre="is advised if there is a contact with someone with" exact="respiratory" post="symptoms. d.Non-essential travel to major affected areas should be"/>
  <result pre="restrict the spread of infection. 4 Measures in Patients of" exact="diabetes" post="with COVID 19 infection a.In case a person with"/>
  <result pre="infection. 4 Measures in Patients of diabetes with COVID 19" exact="infection" post="a.In case a person with diabetes develops fever, cough,"/>
  <result pre="diabetes with COVID 19 infection a.In case a person with" exact="diabetes" post="develops fever, cough, running nose or dyspnoea, the appropriate"/>
  <result pre="health authority needs to be notified as testing for this" exact="disease" post="is available at selected places only. b.The affected person"/>
  <result pre="need to be followed. c.Majority of patients have a mild" exact="disease" post="and can be managed at home. Hydration should be"/>
  <result pre="can be managed at home. Hydration should be maintained and" exact="symptomatic" post="treatment with acetaminophen, steam inhalation etc. can be given."/>
  <result pre="with acetaminophen, steam inhalation etc. can be given. d.Patients with" exact="type 1" post="diabetes should measure blood glucose and urinary ketones frequently"/>
  <result pre="steam inhalation etc. can be given. d.Patients with type 1" exact="diabetes" post="should measure blood glucose and urinary ketones frequently if"/>
  <result pre="measure blood glucose and urinary ketones frequently if fever with" exact="hyperglycemia" post="occurs. Frequent changes in dosage and correctional bolus may"/>
  <result pre="maintain normoglycemia. e.Anti-hyperglycemic agents that can cause volume depletion or" exact="hypoglycemia" post="should be avoided. Dosage of oral anti-diabetic drugs may"/>
  <result pre="of blood glucose and drug adjustment. f.Hospitalised patients with severe" exact="disease" post="need frequent blood glucose monitoring. Oral agents especially metformin"/>
  <result pre="be stopped. g.Insulin is the preferred agent for control of" exact="hyperglycemia" post="in hospitalised sick patients. 5 Unproven therapies and future"/>
  <result pre="sick patients. 5 Unproven therapies and future directions In the" exact="absence of" post="a specific antiviral drug, anecdotal use of drugs like"/>
  <result pre="rennin angiotensin system may have a role in treating severe" exact="respiratory" post="disease [13,14]. Zinc nanoparticles were shown to have inhibitory"/>
  <result pre="angiotensin system may have a role in treating severe respiratory" exact="disease" post="[13,14]. Zinc nanoparticles were shown to have inhibitory effects"/>
  <result pre="Zinc nanoparticles were shown to have inhibitory effects on H1N1" exact="viral" post="load, though their effect in COVID-19 is unknown and"/>
  <result pre="though their effect in COVID-19 is unknown and untested [15]." exact="Vitamin C" post="supplementation has some role in prevention of pneumonia and"/>
  <result pre="[15]. Vitamin C supplementation has some role in prevention of" exact="pneumonia" post="and its effect on COVID-19 needs evaluation [16]. Efforts"/>
  <result pre="a rapidly changing epidemicJÂ Am Med Assoc2020 Feb 2810.1001/jama.2020.3072 2Coronavirus" exact="disease" post="2019 (COVID-19) situation report â€&quot; 45https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200305-sitrep-45-covid-19.pdf?sfvrsn=ed2ba78b_2 3GuanW.J.NiZ.Y.HuY.LiangW.H.OuC.Q.HeJ.X.LiuL.ShanH.LeiC.L.HuiD.S.C.DuB.LiL.J.ZengG.YuenK.Y.ChenR.C.TangC.L.WangT.ChenP.Y.XiangJ.LiS.Y.WangJ.L.LiangZ.J.PengY.X.WeiL.LiuY.HuY.H.PengP.WangJ.M.LiuJ.Y.ChenZ.LiG.ZhengZ.J.QiuS.Q.LuoJ.YeC.J.ZhuS.Y.ZhongN.S.China medical treatment"/>
  <result pre="medical treatment expert group for covid-19. Clinical characteristics of coronavirus" exact="disease" post="2019 in ChinaNÂ Engl J Med2020 Feb 2810.1056/NEJMoa2002032 4FauciA.S.LaneH.C.RedfieldR.R.Covid-19"/>
  <result pre="unchartedNÂ Engl J Med2020 Feb 2810.1056/NEJMe2002387 5YangJ.K.1FengY.YuanM.Y.YuanS.Y.FuH.J.WuB.Y.SunG.Z.YangG.R.ZhangX.L.WangL.XuX.XuX.P.ChanJ.C.Plasma glucose levels and" exact="diabetes" post="are independent predictors for mortality and morbidity in patients"/>
  <result pre="1411E59 8DengS.Q.PengH.J.Characteristics of and public health responses to the coronavirus" exact="disease" post="2019 outbreak in ChinaJÂ Clin Med22020 Feb 20910.3390/jcm9020575E575 9ZhangJ.J.DongX.CaoY.Y.YuanY.D.YangY.B.YanY.Q.AkdisC.A.GaoY.D.Clinical"/>
  <result pre="Mar 310.1515/cclm-2020-0198pii:/j/cclm.ahead-of-print/cclm-2020-0198/cclm-2020-0198.xml 12WuZ.McGooganJ.M.Characteristics of and important lessons from the coronavirus" exact="disease" post="2019 (COVID-19) outbreak in China: summary of a report"/>
  <result pre="report of 72Â 314 cases from the Chinese center for" exact="disease" post="control and preventionJÂ Am Med Assoc2020 Feb 2410.1001/jama.2020.2648 13SunM.L.YangJ.M.SunY.P.SuG.H.Inhibitors"/>
  <result pre="blockers such as Telmisartan, Losartsan in nCoV Wuhan Corona Virus" exact="infections" post="â€&quot; novel mode of treatmentBMJ3682020m406 15GhaffariH.TavakoliA.MoradiA.TabarraeiA.Bokharaei-SalimF.ZahmatkeshanM.FarahmandM.JavanmardD.KianiS.J.EsghaeiM.Pirhajati-MahabadiV.MonavariS.H.Ataei-PirkoohA.Inhibition of H1N1 influenza"/>
  <result pre="infections â€&quot; novel mode of treatmentBMJ3682020m406 15GhaffariH.TavakoliA.MoradiA.TabarraeiA.Bokharaei-SalimF.ZahmatkeshanM.FarahmandM.JavanmardD.KianiS.J.EsghaeiM.Pirhajati-MahabadiV.MonavariS.H.Ataei-PirkoohA.Inhibition of H1N1 influenza" exact="virus infection" post="by zinc oxide nanoparticles: another emerging application of nanomedicineJÂ"/>
  <result pre="â€&quot; novel mode of treatmentBMJ3682020m406 15GhaffariH.TavakoliA.MoradiA.TabarraeiA.Bokharaei-SalimF.ZahmatkeshanM.FarahmandM.JavanmardD.KianiS.J.EsghaeiM.Pirhajati-MahabadiV.MonavariS.H.Ataei-PirkoohA.Inhibition of H1N1 influenza virus" exact="infection" post="by zinc oxide nanoparticles: another emerging application of nanomedicineJÂ"/>
  <result pre="emerging application of nanomedicineJÂ Biomed Sci26120197031500628 16HemilÃ¤H.Vitamin C intake and" exact="susceptibility to" post="pneumoniaPediatr Infect Dis J1691997 Sep8368379306475 17DRAFT landscape of COVID-19"/>
 </snippets>
</snippetsTree>
